Piers Ford

By Piers Ford 03:31 amMay 15, 2019
Industry disruption by digital players is a major threat to the health insurance industry, but insurers themselves seem to be more dazzled by the oncoming glare than galvanised behind comprehensive strategies and best-practice development frameworks for digitising their businesses. While there is a general cohesion around CRM and the customer experience, the deeper benefits of digitisation –...
By Piers Ford 05:39 amApril 30, 2019
Despite the strong push for technology development from the NHS, patient demand for video GP consultations is lagging behind the other options typically offered by digital appointment systems. This is the conclusion of the latest data from askmyGP, which reveals a much higher preference for secure messaging, telephone and face-to-face consultations. The patient contact preference data was...
dementia
By Piers Ford 03:14 amApril 25, 2019
Summary The UK Dementia Research Institute has appointed its seventh research centre – a £20 million facility based at Imperial College London, which will be tasked with developing new technologies to help people live in ‘dementia-friendly’ homes, as well as gathering insights into how the condition develops. With the collaboration of the University of Surrey, the new centre will bring together...
virtual reality
By Piers Ford 05:56 amFebruary 20, 2019
Third Eye NeuroTech’s Blue Room immersive virtual reality (VR) technology is in the spotlight following the publication of research which revealed its effectiveness in treating phobias and anxieties for children and adults. The Blue Room was developed by specialists at Newcastle University in the UK in tandem with the Durham-based tech firm and has been made available as an NHS treatment through...
Doctor talking to patient
By Piers Ford 06:57 amFebruary 13, 2019
Mendelian, a UK healthtech startup, has received a £500,000 grant from Innovate UK to build platforms that will help GPs to identify NHS patients with potentially rare or hard-to-diagnose conditions and diseases more quickly. The two-year £940,000 project is based on Mendelian’s specialised screening system, which provides augmented and automated data analysis to assist with the accurate...